secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nu-Med Plus, Inc. (NUMD)
CIK:        0001543637
Form:       8-K
Filed at:   2024-04-29T23:59:59+00:00
Accession:  0001548123-24-000062
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nu-Med Plus to merge with YourSpace America; YSA's Colvin to become CEO with majority voting control
--------------------------------------------------------------------------------

- 4,500,000 Series A Preferred shares (20:1 voting, convertible into 20 common each) issued to YSA shareholders at closing.
- 1,000,000 Series X Preferred shares (100:1 voting, non-convertible) issued to YSA CEO Russ Colvin, granting majority voting control.
- Upon closing, Colvin becomes President, CEO, Director; William Hayde named Executive Chairman; Merrell and Robins continue as Directors.
- Closing subject to final due diligence; no purchase price or financial terms disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1543637/000154812324000062/0001548123-24-000062-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1543637/000154812324000062/numd8-k42524.htm
  HTML page:      https://secwatch.observer/filing/0001548123-24-000062

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer